219 related articles for article (PubMed ID: 20064928)
1. Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching.
Curnis F; Cattaneo A; Longhi R; Sacchi A; Gasparri AM; Pastorino F; Di Matteo P; Traversari C; Bachi A; Ponzoni M; Rizzardi GP; Corti A
J Biol Chem; 2010 Mar; 285(12):9114-23. PubMed ID: 20064928
[TBL] [Abstract][Full Text] [Related]
2. The neovasculature homing motif NGR: more than meets the eye.
Corti A; Curnis F; Arap W; Pasqualini R
Blood; 2008 Oct; 112(7):2628-35. PubMed ID: 18574027
[TBL] [Abstract][Full Text] [Related]
3. Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides.
Huang Y; Cheng Q; Jin X; Ji JL; Guo S; Zheng S; Wang X; Cao H; Gao S; Liang XJ; Du Q; Liang Z
Biomater Sci; 2016 Mar; 4(3):494-510. PubMed ID: 26783563
[TBL] [Abstract][Full Text] [Related]
4. NGR-TNF Engineering with an N-Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity.
Corti A; Gasparri AM; Sacchi A; Colombo B; Monieri M; Rrapaj E; Ferreri AJM; Curnis F
Mol Pharm; 2020 Oct; 17(10):3813-3824. PubMed ID: 32805112
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrin.
Spitaleri A; Mari S; Curnis F; Traversari C; Longhi R; Bordignon C; Corti A; Rizzardi GP; Musco G
J Biol Chem; 2008 Jul; 283(28):19757-68. PubMed ID: 18480047
[TBL] [Abstract][Full Text] [Related]
6. Isoaspartate-dependent molecular switches for integrin-ligand recognition.
Corti A; Curnis F
J Cell Sci; 2011 Feb; 124(Pt 4):515-22. PubMed ID: 21282473
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C
PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440
[TBL] [Abstract][Full Text] [Related]
8. Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif.
Curnis F; Sacchi A; Gasparri A; Longhi R; Bachi A; Doglioni C; Bordignon C; Traversari C; Rizzardi GP; Corti A
Cancer Res; 2008 Sep; 68(17):7073-82. PubMed ID: 18757422
[TBL] [Abstract][Full Text] [Related]
9. Glycine
Corti A; Gasparri AM; Ghitti M; Sacchi A; Sudati F; Fiocchi M; Buttiglione V; Perani L; Gori A; Valtorta S; Moresco RM; Pastorino F; Ponzoni M; Musco G; Curnis F
Adv Funct Mater; 2017 Sep; 27(36):. PubMed ID: 28979182
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous formation of L-isoaspartate and gain of function in fibronectin.
Curnis F; Longhi R; Crippa L; Cattaneo A; Dondossola E; Bachi A; Corti A
J Biol Chem; 2006 Nov; 281(47):36466-76. PubMed ID: 17015452
[TBL] [Abstract][Full Text] [Related]
11. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.
Bochen A; Marelli UK; Otto E; Pallarola D; Mas-Moruno C; Di Leva FS; Boehm H; Spatz JP; Novellino E; Kessler H; Marinelli L
J Med Chem; 2013 Feb; 56(4):1509-19. PubMed ID: 23362923
[TBL] [Abstract][Full Text] [Related]
12. NGR-tagged nano-gold: A new CD13-selective carrier for cytokine delivery to tumors.
Curnis F; Fiocchi M; Sacchi A; Gori A; Gasparri A; Corti A
Nano Res; 2016 May; 9(5):1393-1408. PubMed ID: 27226823
[TBL] [Abstract][Full Text] [Related]
13. NGR-peptide-drug conjugates with dual targeting properties.
Enyedi KN; Tóth S; Szakács G; Mező G
PLoS One; 2017; 12(6):e0178632. PubMed ID: 28575020
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif.
Colombo G; Curnis F; De Mori GM; Gasparri A; Longoni C; Sacchi A; Longhi R; Corti A
J Biol Chem; 2002 Dec; 277(49):47891-7. PubMed ID: 12372830
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.
Negussie AH; Miller JL; Reddy G; Drake SK; Wood BJ; Dreher MR
J Control Release; 2010 Apr; 143(2):265-73. PubMed ID: 20067811
[TBL] [Abstract][Full Text] [Related]
16. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery.
Tripodi AAP; Ranđelović I; Biri-Kovács B; Szeder B; Mező G; Tóvári J
Pathol Oncol Res; 2020 Jul; 26(3):1879-1892. PubMed ID: 31820302
[TBL] [Abstract][Full Text] [Related]
18. Integrin αvβ3 and disulfide bonds play important roles in NGR-retargeted adenovirus transduction efficiency.
Nestić D; Hozić A; Brkljača Z; Butorac A; Pažur K; Jullienne B; Cindrić M; Ambriović-Ristov A; Benihoud K; Majhen D
Life Sci; 2022 Feb; 291():120116. PubMed ID: 34740576
[TBL] [Abstract][Full Text] [Related]
19. NGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequences.
Soudy R; Ahmed S; Kaur K
ACS Comb Sci; 2012 Nov; 14(11):590-9. PubMed ID: 23030271
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-labeled cyclic NGR peptide for microPET imaging of CD13 receptor expression.
Shao Y; Liang W; Kang F; Yang W; Ma X; Li G; Zong S; Chen K; Wang J
Molecules; 2014 Aug; 19(8):11600-12. PubMed ID: 25100253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
